Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Drug Res (Stuttg) ; 66(8): 407-14, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27224907

RESUMO

AIM: The role of guggulipid was evaluated in high fat diet and middle cerebral artery occlusion (MCAO) induced ischemic cerebral dysfunctions in rats of either sex. MATERIALS AND METHODS: Ethyl acetate extract of guggul known as guggulipid was prepared and administered to rats. Animals were divided into 9 groups, consisting 6 rats, each receiving different treatments per orally for 8 weeks. Control group rats received normal control diet while rest of the other groups animals were fed high fat diet (HFD) for 8 weeks. Cerebral ischemia was induced for 2 h followed by reperfusion for 22 h. Locomotor activity and grip strength tests were performed immediately after 24 h of reperfusion followed by biochemical estimations and histopathology. RESULTS: Locomotor activity and grip strength were significantly decreased in HFD and HFD fed MCAO groups and improved significantly in pretreatment groups. Cerebral infarction, thiobarbituric acid reactive substances (TBARs), nitric oxide and tumor necrosis factor alfa (TNFα) levels were increased, pretreatment of guggulipid alone and with aspirin significantly reduced these markers. Reduced glutathione (GSH), superoxide dismutase (SOD) and catalase, levels were decreased but all drug pretreated groups showed significant improvement in those markers. CONCLUSION: Guggulipid demonstrated neuroprotection owing to its hypolipidemic, antioxidant, anti-inflammatory and anti-thrombotic activities but further research is warranted to confirm its role in cerebral ischemia.


Assuntos
Isquemia Encefálica/tratamento farmacológico , Fármacos Neuroprotetores/uso terapêutico , Extratos Vegetais/uso terapêutico , Gomas Vegetais/uso terapêutico , Animais , Aspirina/administração & dosagem , Aspirina/uso terapêutico , Atorvastatina/administração & dosagem , Atorvastatina/uso terapêutico , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Isquemia Encefálica/metabolismo , Isquemia Encefálica/fisiopatologia , Catalase/metabolismo , Commiphora , Dieta Hiperlipídica , Quimioterapia Combinada , Feminino , Glutationa/metabolismo , Força da Mão , Infarto da Artéria Cerebral Média/tratamento farmacológico , Peroxidação de Lipídeos , Locomoção/efeitos dos fármacos , Masculino , Fármacos Neuroprotetores/administração & dosagem , Fitoterapia , Extratos Vegetais/administração & dosagem , Gomas Vegetais/administração & dosagem , Ratos , Superóxido Dismutase/antagonistas & inibidores , Superóxido Dismutase/metabolismo
2.
Nat Prod Res ; 25(17): 1666-70, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21714728

RESUMO

This study was undertaken to quantify psoralen and daidzein by high-performance thin layer chromatography (HPTLC). The methanolic extract of 10 mg mL(-1) concentration solution was prepared for HPTLC quantification of psoralen and daidzein. HPTLC aluminium-backed plates coated with 0.2 mm layers of silica gel 60 F(254) were used as the stationary phase. The working standard solution of psoralen and daidzein was applied along with the test sample solution by means of Camag Linomat IV sample applicator. R (f) values of psoralen and daidzein were found to be 0.60 and 0.88, whilst as their percentage values in methanolic extract were found to be 3.02% and 5.64% (w/w), respectively. A simple quantitative estimation method of psoralen and daidzein by HPTLC is reported that can be used for the quality control of marketed preparations containing Ficus carica. However, further study is warranted to isolate and quantify active constituents present in the leaves of F. carica by sophisticated techniques.


Assuntos
Ficus/química , Ficusina/análise , Isoflavonas/análise , Extratos Vegetais/análise , Folhas de Planta/química , Cromatografia em Camada Fina , Metanol
3.
J Pharm Bioallied Sci ; 2(4): 329-32, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21180466

RESUMO

OBJECTIVE: Jigrine is a herbal hepatoprotective formulation containing aqueous extracts of 14 medicinal plants. Present study was designed to evaluate per se neuropharmacological effects of jigrine in mice. MATERIALS AND METHODS: Jigrine was evaluated in a number of pharmacological test paradigms, viz. open field arena, actophotometer, hole board, rotarod, traction test, grip strength test, spontaneous alternation behavior, passive avoidance task, and phenobarbital sleeping time. RESULTS AND CONCLUSIONS: Jigrine pretreatment (1 and 2 ml/kg, p.o.) did not produce any significant effect as compared to normal saline treated animals and was found to be free from any acute undesirable central effects at these two dose levels.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA